You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:
Business Description: Narhex Life Sciences Limited (NLS) is an Australian biotechnology company with principal activities involving in the development, manufacture and marketing of HIV related diagnostics and therapeutic products of NLS’ Intellectual Property. The Company’s lead drug development is the anti-HIV protease inhibitor DG-17, a water-soluble pro-drug of the active anti-HIV drug DG-35. In 2010, NLS entered into the Deed of Company Arrangement.
The Age 18/05/2013 |
As Australia's major retailers increase their online sales channels, pouring millions into their websites, they could face new competition from China's booming e-commerce industry.
The Age 18/05/2013 |
Most of those who take a political approach to the budget assume that if it's in deficit, the way you get it back to surplus is to cut government spending or, if you're a really bad person, increase taxes. They forget it's the budget itself that's supposed to do the heavy lifting.
Already a member? 
